CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Prostatic Hyperplasia

  • A Pilot Study on the Effects of Yi Jin Jing Exercise for Older Men with Benign Prostatic Hyperplasia.

    facebook Share on Facebook
    Abstract Title:

    A Pilot Study on the Effects of Yi Jin Jing Exercise for Older Men with Benign Prostatic Hyperplasia.

    Abstract Source:

    J Aging Phys Act. 2020 May 20:1-6. Epub 2020 May 20. PMID: 32434151

    Abstract Author(s):

    ZhiWei Liu, Ting Chen, Mingkang Shen, Kai Li, ChunJie Ma, Antonnette Ketlhoafetse, XiangYun Liu

    Article Affiliation:

    ZhiWei Liu

    Abstract:

    Benign prostatic hyperplasia and its associated lower urinary tract symptoms seriously affect both the physical and mental health of older men. In order to determine the efficiency of Chinese Qigong Yi Jin Jing on prostate health in older individuals, thirty participants were randomized into either an Yi Jin Jing group (n = 15) or a control group (n = 15). After the 6-month intervention, the Yi Jin Jing group showed a significant decrease in international prostate symptom score and a significant increase in maximal urinary flow rate (compared with the control group p = .005, p = .001, respectively). Also, testosterone level increased and estrogen/testosterone ratio decreased in the Yi Jin Jing group (compared with the baseline p = .004, p = .002, respectively); estrogen level and estrogen/testosterone ratio were lower in the Yi Jin Jing group (compared with the control group p = .029, p = .012, respectively). The results showed that Yi Jin Jing is a promising way to reduce the risk of benign prostatic hyperplasia-lower urinary tract symptoms in older men.

  • Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.

    facebook Share on Facebook
    Abstract Title:

    Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.

    Abstract Source:

    PLoS One. 2017 ;12(4):e0174586. Epub 2017 Apr 4. PMID: 28376120

    Abstract Author(s):

    Wei Zhang, Liyan Ma, Brent A Bauer, Zhishun Liu, Yao Lu

    Article Affiliation:

    Wei Zhang

    Abstract:

    PURPOSE:This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign prostatic hyperplasia (BPH) in randomized controlled trials (RCTs).

    METHODS:We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, the Chinese Biomedical Database, the China National Knowledge Infrastructure, the VIP Database and the Wanfang Database. Parallel-group RCTs of acupuncture for men with symptomatic BPH were included. Data from the included trials were extracted by two independent reviewers and were analyzed with The Cochrane Collaboration Review Manager software (RevMan 5.3.5) after risk of bias judgments. The primary outcome measure of this review was a change in urological symptoms.

    RESULTS:Eight RCTs, which involved 661 men with BPH, were included. Follow-up varied from 4 weeks to 18 months. Pooling of the data from three trials that compared acupuncture with sham-acupuncture revealed that in the short term (4-6 weeks), acupuncture can significantly improve IPSS (MD -1.90, 95% CI -3.58 to -0.21). A sensitivity analysis of the short-term endpoint showed the same result (MD -3.01, 95% CI -5.19 to -0.84) with a borderline minimal clinical important difference (MCID). Qmax of the short-term endpoint indicated statistically positive beneficial effects of acupuncture (MD -1.78, 95%CI -3.43, -0.14). A meta-analysis after medium-term follow-up (12-18 weeks) indicated no significant effect on IPSS when the data from two trials were combined (MD -2.04, 95% CI -4.19, 0.10).

    CONCLUSION:Statistically significant changes were observed in favor of acupuncture in moderate to severe BPH with respect to short-term follow-up endpoints. The clinical significance of these changes needs to be tested by further studies with rigorous designs and longer follow-up times.

    TRIAL REGISTRATION NUMBER:PROSPERO CRD42014013645.

  • Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis📎

    facebook Share on Facebook
    Abstract Title:

    Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis.

    Abstract Source:

    PLoS One. 2017 ;12(4):e0174586. Epub 2017 Apr 4. PMID: 28376120

    Abstract Author(s):

    Wei Zhang, Liyan Ma, Brent A Bauer, Zhishun Liu, Yao Lu

    Article Affiliation:

    Wei Zhang

    Abstract:

    PURPOSE:This systematic review and meta-analysis aims to assess the therapeutic and adverse effects of acupuncture for benign prostatic hyperplasia (BPH) in randomized controlled trials (RCTs).

    METHODS:We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, the Chinese Biomedical Database, the China National Knowledge Infrastructure, the VIP Database and the Wanfang Database. Parallel-group RCTs of acupuncture for men with symptomatic BPH were included. Data from the included trials were extracted by two independent reviewers and were analyzed with The Cochrane Collaboration Review Manager software (RevMan 5.3.5) after risk of bias judgments. The primary outcome measure of this review was a change in urological symptoms.

    RESULTS:Eight RCTs, which involved 661 men with BPH, were included. Follow-up varied from 4 weeks to 18 months. Pooling of the data from three trials that compared acupuncture with sham-acupuncture revealed that in the short term (4-6 weeks), acupuncture can significantly improve IPSS (MD -1.90, 95% CI -3.58 to -0.21). A sensitivity analysis of the short-term endpoint showed the same result (MD -3.01, 95% CI -5.19 to -0.84) with a borderline minimal clinical important difference (MCID). Qmax of the short-term endpoint indicated statistically positive beneficial effects of acupuncture (MD -1.78, 95%CI -3.43, -0.14). A meta-analysis after medium-term follow-up (12-18 weeks) indicated no significant effect on IPSS when the data from two trials were combined (MD -2.04, 95% CI -4.19, 0.10).

    CONCLUSION:Statistically significant changes were observed in favor of acupuncture in moderate to severe BPH with respect to short-term follow-up endpoints. The clinical significance of these changes needs to be tested by further studies with rigorous designs and longer follow-up times.

    TRIAL REGISTRATION NUMBER:PROSPERO CRD42014013645.